Cacti Asset Management’s Novo Nordisk NVO Stock Holding History

Cacti Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$767K	Hold	16,000	–	–	0.04%	58
2026 Q1	$588K	Hold	16,000	–	–	0.04%	59
2025 Q4	$824K	Hold	16,000	–	–	0.05%	57
2025 Q3	$890K	Buy	16,000 +6,000	+60%	+$351K	0.06%	52
2025 Q2	$685K	Hold	10,000	–	–	0.05%	55
2025 Q1	$693K	Hold	10,000	–	–	0.05%	54
2024 Q4	$857K	Hold	10,000	–	–	0.06%	53
2024 Q3	$1.25M	Hold	10,000	–	–	0.09%	48
2024 Q2	$1.44M	Hold	10,000	–	–	0.11%	46
2024 Q1	$1.36M	Sell	10,000 -1,000	-9%	-$119K	0.11%	47
2023 Q4	$1.14M	Hold	11,000	–	–	0.1%	47
2023 Q3	$1M	Hold	11,000	–	–	0.09%	48
2023 Q2	$890K	Hold	11,000	–	–	0.08%	52
2023 Q1	$875K	Hold	11,000	–	–	0.08%	53
2022 Q4	$744K	Hold	11,000	–	–	0.07%	52
2022 Q3	$548K	Hold	11,000	–	–	0.05%	56
2022 Q2	$613K	Hold	11,000	–	–	0.06%	56
2022 Q1	$614K	Buy	+11,000	New	+$565K	0.05%	55

Other funds holding NVO

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

AIIMS

Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

GIM

Generate Investment Management Auckland, New Zealand $2.43B AUM 37.24% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

Cacti Asset Management's NVO Position: Q2 2026 in Review

Cacti Asset Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 16,000 shares worth $767K. The position accounts for 0.04% of the portfolio, ranked #58.

Cacti Asset Management first reported a position in NVO in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.44M in Q2 2024. 543 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Cacti Asset Management held 16,000 shares of Novo Nordisk worth $767K as of Q2 2026.
Cacti Asset Management left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.04% of Cacti Asset Management's portfolio in Q2 2026, its #58 holding.
Cacti Asset Management first reported a position in Novo Nordisk in Q1 2022 and has held it in 18 quarters since.
Cacti Asset Management's Novo Nordisk position peaked at $1.44M in Q2 2024.
543 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Cacti Asset Management's 13F filing for Q2 2026, filed 1 Jul 2026.